OncoHost Raises $35M For Precision Oncology Diagnostic Solution
Israeli personalized cancer therapy company OncoHost, announced on Tuesday that it raised $35 million in a Series C funding round to finance its multicenter PROPHETIC trial that tests the company’s machine-learning-based host response profiling platform PROphet, a precision oncology diagnostic solution. The funding will also be used to support the company’s commercial launch, which is […]
May 11, 2022
OncoHost’s Focus On The Patient Offers Precision Oncology To Combat Cancer
OncoHost's platform combines proteomic analysis with AI to predict host responses to immunotherapy, and gain insight into cancer treatments.
July 06, 2021
Zebra Medical Vision Gets FDA Clearance For Mammography Solution
This is the Israeli AI imaging company's 6th FDA clearance for an automated solution that helps identify at-risk patients and helps radiologists with workflow.
July 27, 2020
Israeli Startup Nucleai Raises $6.5M For Its AI Precision Oncology System
Founded in 2017, Nucleai developed a platform that leverages tissue datasets to produce insights into cancer biology, increase clinical trial efficacy and improve patient care.
July 08, 2020
Sheba Medical Center Partners With Tele-Medicine Startup For At-Home Cancer Patient Monitoring
The program will be piloted within Sheba's Oncology Department and will be offered to several hundred patients.
September 01, 2019